FDA Drug Application (012737) for WILPO by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number012737
Product Number001
FormTABLET;ORAL
Dosage8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameWILPO
Active IngredientPHENTERMINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient PHENTERMINE HYDROCHLORIDE11


Back to FDA Applications sponsored by SANDOZ